VENUS REMEDIES
|
The Current P/S Ratio of VENUS REMEDIES is 0.96.
Share Price | ₹481.2 | Aug 26,2025 |
Market Cap | ₹644.8 Cr | |
Sales-TTM | ₹671.2 Cr | TTM-Consolidated Results |
Price/Sales | 0.96x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of VENUS REMEDIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹644.8 Cr] as on Aug 26,2025
(/) Sales [ ₹671.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.96x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay '0.96 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VENUS REMEDIES !
The chart below summarizes the trend in P/S Ratio of VENUS REMEDIES over the last five years.
Historical PS (Price/Sales) ratio chart of VENUS REMEDIES
PS Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.59x.
- VENUS REMEDIES 's operated at median p/e ratio of 0.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 0.73x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2023 of 0.39x.
How does VENUS REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
VENUS REMEDIES | 671.2 | 0.96 | 644.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.14 | 384,002.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 17.03 | 164,334.0 |
CIPLA LTD | 27,811.2 | 4.59 | 127,613.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.30 | 121,923.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.15 | 105,437.0 |
MANKIND PHARMA LTD | 12,956.2 | 7.97 | 103,211.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.21 | 99,370.6 |
LUPIN LTD | 23,375.9 | 3.76 | 87,870.4 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.90 | 60,711.2 |
ABBOTT INDIA LTD | 6,589.9 | 10.30 | 67,847.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VENUS REMEDIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 0.96x |
Max industry PS | 17.03x |
Median industry PS | 4.59x |
Average industry PS | 6.48x |
You may also like the below Video Courses